Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNP) against multidrug resistant

Emerson Danguy Cavassin1, Luiz Francisco Poli de Figueiredo2, José Pinhata Otoch3

  • 1Department of Infectious Diseases, University of São Paulo, São Paulo, Brazil. emerson_danguy@yahoo.com.br.

Abstract

Insights

Silver nanoparticles show promise for treating multidrug-resistant infections, particularly against Gram-negative bacteria. Citrate and chitosan-stabilized silver nanoparticles demonstrated superior in vitro activity compared to commercial versions and controls.

Area of Science:

  • Nanotechnology
  • Microbiology
  • Infectious Diseases

Background:

  • Multidrug-resistant (MDR) microorganisms pose a significant global health threat.
  • Novel antimicrobial agents are urgently needed to combat resistant bacterial infections.
  • Silver nanoparticles (AgNPs) are being investigated as potential therapeutic agents.

Purpose of the Study:

  • To evaluate the in vitro antimicrobial activity of different silver nanoparticles (AgNPs).
  • To compare the efficacy of AgNPs against both susceptible and multidrug-resistant bacteria.
  • To assess various in vitro methods for evaluating AgNP antimicrobial effects.

Main Methods:

  • Tested AgNPs stabilized with citrate, chitosan, and polyvinyl alcohol, plus a commercial AgNP.
  • Included silver sulfadiazine and silver nitrate as controls.
  • Employed agar diffusion, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and time-kill assays.

Main Results:

  • AgNPs exhibited inhibitory activity against both susceptible and MDR Gram-positive and Gram-negative bacteria.
  • Citrate and chitosan AgNPs showed the best performance, with an MIC90 of 6.75 μg/mL.
  • In vitro activity was greater against Gram-negative than Gram-positive bacteria.
  • Bactericidal effects were more pronounced against antimicrobial-susceptible bacteria.

Conclusions:

  • Agar diffusion can serve as an effective initial screening method for AgNP activity.
  • MIC/MBC and time-kill assays are valuable for detailed evaluation of AgNP efficacy.
  • Citrate and chitosan AgNPs outperformed commercial AgNPs and silver salt controls.
  • AgNPs, particularly against Gram-negative MDR bacteria, represent a promising future therapeutic option given the limited availability of new antibiotics.